Annual CFF
$91.87 M
+$81.41 M+777.89%
December 31, 2023
Summary
- As of February 8, 2025, PRAX annual cash flow from financing activities is $91.87 million, with the most recent change of +$81.41 million (+777.89%) on December 31, 2023.
- During the last 3 years, PRAX annual CFF has fallen by -$212.54 million (-69.82%).
- PRAX annual CFF is now -69.82% below its all-time high of $304.42 million, reached on December 31, 2020.
Performance
PRAX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.44 M
-$214.93 M-99.34%
September 30, 2024
Summary
- As of February 8, 2025, PRAX quarterly cash flow from financing activities is $1.44 million, with the most recent change of -$214.93 million (-99.34%) on September 30, 2024.
- Over the past year, PRAX quarterly CFF has dropped by -$181.32 million (-99.21%).
- PRAX quarterly CFF is now -99.34% below its all-time high of $216.36 million, reached on June 30, 2024.
Performance
PRAX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$404.68 M
+$1.44 M+0.36%
September 30, 2024
Summary
- As of February 8, 2025, PRAX TTM cash flow from financing activities is $404.68 million, with the most recent change of +$1.44 million (+0.36%) on September 30, 2024.
- Over the past year, PRAX TTM CFF has increased by +$148.12 million (+57.74%).
- PRAX TTM CFF is now -1.45% below its all-time high of $410.63 million, reached on June 30, 2021.
Performance
PRAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PRAX Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +777.9% | -99.2% | +57.7% |
3 y3 years | -69.8% | -92.0% | +1380.9% |
5 y5 years | +143.0% | -92.0% | +1380.9% |
PRAX Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -14.6% | +777.9% | -99.3% | -100.0% | at high | +4098.8% |
5 y | 5-year | -69.8% | +777.9% | -99.3% | +104.8% | -1.4% | +1448.9% |
alltime | all time | -69.8% | +777.9% | -99.3% | +104.8% | -1.4% | +1448.9% |
Praxis Precision Medicines Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $1.44 M(-99.3%) | $404.68 M(+0.4%) |
Jun 2024 | - | $216.36 M(+18.4%) | $403.25 M(+57.2%) |
Mar 2024 | - | $182.76 M(+4329.4%) | $256.56 M(+179.3%) |
Dec 2023 | $91.87 M(+777.9%) | $4.13 M(>+9900.0%) | $91.87 M(-1.4%) |
Sep 2023 | - | $0.00(-100.0%) | $93.13 M(-3.5%) |
Jun 2023 | - | $69.67 M(+285.6%) | $96.50 M(+253.1%) |
Mar 2023 | - | $18.07 M(+235.4%) | $27.33 M(+161.1%) |
Dec 2022 | $10.46 M | $5.39 M(+60.1%) | $10.46 M(-18.2%) |
Sep 2022 | - | $3.37 M(+567.7%) | $12.79 M(+32.7%) |
Jun 2022 | - | $504.00 K(-58.3%) | $9.64 M(-91.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $1.21 M(-84.3%) | $108.52 M(+0.9%) |
Dec 2021 | $107.59 M(-64.7%) | $7.71 M(+3538.2%) | $107.59 M(-64.4%) |
Sep 2021 | - | $212.00 K(-99.8%) | $301.94 M(-26.5%) |
Jun 2021 | - | $99.39 M(>+9900.0%) | $410.63 M(+22.7%) |
Mar 2021 | - | $276.00 K(-99.9%) | $334.69 M(+9.9%) |
Dec 2020 | $304.42 M(+404.1%) | $202.06 M(+85.5%) | $304.42 M(+197.4%) |
Sep 2020 | - | $108.91 M(+364.5%) | $102.35 M(-1661.7%) |
Jun 2020 | - | $23.45 M(-178.2%) | -$6.55 M(-78.2%) |
Mar 2020 | - | -$30.00 M | -$30.00 M |
Dec 2019 | $60.39 M(+59.7%) | - | - |
Dec 2018 | $37.80 M | - | - |
FAQ
- What is Praxis Precision Medicines annual cash flow from financing activities?
- What is the all time high annual CFF for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual CFF year-on-year change?
- What is Praxis Precision Medicines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly CFF year-on-year change?
- What is Praxis Precision Medicines TTM cash flow from financing activities?
- What is the all time high TTM CFF for Praxis Precision Medicines?
- What is Praxis Precision Medicines TTM CFF year-on-year change?
What is Praxis Precision Medicines annual cash flow from financing activities?
The current annual CFF of PRAX is $91.87 M
What is the all time high annual CFF for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual cash flow from financing activities is $304.42 M
What is Praxis Precision Medicines annual CFF year-on-year change?
Over the past year, PRAX annual cash flow from financing activities has changed by +$81.41 M (+777.89%)
What is Praxis Precision Medicines quarterly cash flow from financing activities?
The current quarterly CFF of PRAX is $1.44 M
What is the all time high quarterly CFF for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly cash flow from financing activities is $216.36 M
What is Praxis Precision Medicines quarterly CFF year-on-year change?
Over the past year, PRAX quarterly cash flow from financing activities has changed by -$181.32 M (-99.21%)
What is Praxis Precision Medicines TTM cash flow from financing activities?
The current TTM CFF of PRAX is $404.68 M
What is the all time high TTM CFF for Praxis Precision Medicines?
Praxis Precision Medicines all-time high TTM cash flow from financing activities is $410.63 M
What is Praxis Precision Medicines TTM CFF year-on-year change?
Over the past year, PRAX TTM cash flow from financing activities has changed by +$148.12 M (+57.74%)